Currently, effective treatments for sarcopenia are still very limited
Making sure youre consuming enough proteinand at the right timesis key to minimizing or avoiding muscle loss when taking GLP-1s, says Obici
In recent years, there has been a marked increase in the registration of global clinical trials examining CAR-T therapies for SLE, with clinicaltrials.gov indicating over 30 registered trials ( Taken together, this review aims to evaluate the potential of CAR-T cell therapy in treating SLE\-related diseases
Patients should avoid injecting into affected areas until evaluated by a healthcare provider
Tirzepatide(Tirzepatide - Oral Dissolving Tablets) Dual-Action Needle-Free Weight Loss Needle-free dual-action GLP-1/GIP medication
Results indicated thatexposure to tirzepatide remained consistent across all groups, and there were no significant impacts on its pharmacokinetics.Reported adverse events were mostly mild and related to the gastrointestinal system in the renal impairment groups [81]